| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/09/2002 | US6417184 Triple drug therapy for the treatment and prevention of acute or chronic pain |
| 07/09/2002 | US6417172 Prevention and treatment of pulmonary bacterial infection or symptomatic pulmonary exposure to endotoxin by inhalation of antiendotoxin drugs |
| 07/09/2002 | US6417170 Administering to skin a composition containing deoxyribonucleosides in concentrations sufficient to enhance dna repair or reduce mutation frequency in a vehicle capable of delivering deoxyribonucleosides to skin cells |
| 07/09/2002 | US6417169 Insulin-like growth factor II antisense oligonucleotide sequences and methods of using same to inhibit cell growth |
| 07/09/2002 | US6417168 Anticancer treatment with killing cells |
| 07/09/2002 | US6417162 Female impotence treated with heterocyclic compound containing nitro groups |
| 07/09/2002 | US6416991 Genetic engineered protein |
| 07/09/2002 | US6416976 TrpS |
| 07/09/2002 | US6416968 Methods of inhibiting Helicobacter pylori |
| 07/09/2002 | US6416794 Methods and compositions for treating cataracts using substances derived from yeast or saltbush |
| 07/09/2002 | US6416765 Botulinum toxin injected into the pancreas |
| 07/09/2002 | US6416758 Antibody conjugate kits for selectively inhibiting VEGF |
| 07/09/2002 | US6415797 Treatment of human herpesviruses using hyperthermia |
| 07/09/2002 | CA2061566C Treatment of disease employing hyaluronic acid and nsaids |
| 07/09/2002 | CA2053468C Prolonged release preparation and polymers thereof |
| 07/04/2002 | WO2002052273A1 Screening method based on siah-numb interaction |
| 07/04/2002 | WO2002052270A2 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| 07/04/2002 | WO2002052268A1 A screening assay for antagonists of human leukocyte receptors |
| 07/04/2002 | WO2002052267A1 A method of assaying for agonists or antagonist of dynorphin a binding to the mas receptor |
| 07/04/2002 | WO2002052036A2 Identification of modulators of dham-kinase and inflammatory diseases |
| 07/04/2002 | WO2002052018A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/04/2002 | WO2002052004A1 Gene involved in apoptosis regulation |
| 07/04/2002 | WO2002051994A2 Polypeptides |
| 07/04/2002 | WO2002051988A2 Thymic epithelial progenitor cells and uses thereof |
| 07/04/2002 | WO2002051981A2 Defects in periaxin associated with myelinopathies |
| 07/04/2002 | WO2002051868A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2002051848A2 Sulfamidothienopyrimidines and the use of the same as phosphodiesterase v inhibitors |
| 07/04/2002 | WO2002051841A1 Quinuclidine carbamate derivatives and their use as m3 antagonists |
| 07/04/2002 | WO2002051814A1 Benzoylpyridazines |
| 07/04/2002 | WO2002051808A2 Muscarinic antagonists |
| 07/04/2002 | WO2002051502A1 Combined inhibition of phosphodiesterase-4 (pde-4) and phosphodiesterase-3 (pde-3) as a therapy for th1-mediated autoimmune diseases |
| 07/04/2002 | WO2002051442A1 Concomitant drugs |
| 07/04/2002 | WO2002051441A1 Medicinal compositions containing diuretic and insulin resistance-improving agent |
| 07/04/2002 | WO2002051440A1 Combination drugs |
| 07/04/2002 | WO2002051437A1 Induction of tolerance |
| 07/04/2002 | WO2002051435A2 New therapeutic uses of smr1 peptides |
| 07/04/2002 | WO2002051434A2 Modulation of smr1-nep interactions in cns disorders giving rise to mental disorders |
| 07/04/2002 | WO2002051433A2 Use of artemin, a member of the gdnf ligand family for preparing a neuroprotective medicament |
| 07/04/2002 | WO2002051430A2 Methods of modulating toll-related receptor (trr) signaling |
| 07/04/2002 | WO2002051420A2 Methods and formulations for the treatment of female sexual dysfunction |
| 07/04/2002 | WO2002051412A1 Medicinal compositions containing aspirin |
| 07/04/2002 | WO2002051410A2 Phenylthiazole and thiazoline derivatives and their use as antiparasitics |
| 07/04/2002 | WO2002051355A2 Acetyl-coenzyme a carboxylase 2 as a target in fat regulation and insulin action |
| 07/04/2002 | WO2002051237A2 Helicobacter proteins, nucleic acids and uses thereof |
| 07/04/2002 | WO2002033100A3 Regulation of human adenylate cyclase, type iv |
| 07/04/2002 | WO2002032393A3 Medicinal composition and in particular its use in fluid therapy |
| 07/04/2002 | WO2002030351A3 Improvement of graft acceptance through manipulation of thymic regeneration |
| 07/04/2002 | WO2002026988A9 Human drug metabolizing enzymes |
| 07/04/2002 | WO2002022110A3 Contraception process and administration form for the same |
| 07/04/2002 | WO2002020486A3 Picolinic acid derivatives for the prevention and treatment of cancer in animals |
| 07/04/2002 | WO2002017898A3 Compositions and methods for inducing vasorelaxation |
| 07/04/2002 | WO2002005848A3 Use of cox-2 inhibitors in the treatment and prevention of ocular cox-2 mediated disorders |
| 07/04/2002 | WO2002002624A3 B7-like molecules and uses thereof |
| 07/04/2002 | WO2001092492A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 07/04/2002 | WO2001090148A8 Neurotransmitter transporters |
| 07/04/2002 | WO2001082916A3 Combination therapeutic compositions and methods of use |
| 07/04/2002 | WO2001078783A3 Compositions comprising natural agents for treatment of cancer |
| 07/04/2002 | WO2001078711A3 Pde-v inhibitors for treatment of parkinson's disease |
| 07/04/2002 | WO2001077169A3 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides |
| 07/04/2002 | WO2001070266A3 Method of inhibiting stenosis and restenosis with a mixture of antibodies anti cd18 and anti ccr2 |
| 07/04/2002 | WO2001068855A3 Gtp-binding protein gamma-12 subunit |
| 07/04/2002 | WO2001062257A3 Bupropion metabolites and methods of their synthesis and use |
| 07/04/2002 | WO2001036007A3 Compositions of a combination of radioactive therapy and cell-cycle inhibitors |
| 07/04/2002 | WO2000074687A9 Antisense modulation of b7 protein expression |
| 07/04/2002 | WO2000069897A9 Modulation of glgf motif (dhr/pdz) containing proteins interaction with cd3n in t lymphocytes |
| 07/04/2002 | US20020086996 N-cyanomethyl amides which are cysteine protease inhibitors; treating osteoporosis; mixtures with bisphosphonates |
| 07/04/2002 | US20020086972 Adaptor protein FRS2 and related products and methods |
| 07/04/2002 | US20020086894 Namely rofecoxib and lovastatin, respectively, with a glutathione pathway enhancing and detoxifying compound, cystine; treatment of prostate or pancreatic cancer by selectively weakening cancer cells via cholesterol pathways |
| 07/04/2002 | US20020086885 Pharmaceutical composition |
| 07/04/2002 | US20020086881 As well as 5-HT3 antagonists and 5-HT4 agonists; for preventing or managing gastro-esophageal reflux disease and/or emesis |
| 07/04/2002 | US20020086880 Methods and compositions using (+) norcisapride in combination with proton pump inhibitors or H2 receptor antagonists |
| 07/04/2002 | US20020086878 Monomolecular dispersions of various medicaments prepared for transmucosal delivery; treatment of respiratory illness such as cold and/or allergy |
| 07/04/2002 | US20020086873 Hair loss prevention |
| 07/04/2002 | US20020086871 Pharmaceutical composition for the treatment of CNS and other disorders |
| 07/04/2002 | US20020086870 Pharmacological treatment for sleep apnea |
| 07/04/2002 | US20020086864 Administering optically pure (S,S) enantiomer of reboxetine |
| 07/04/2002 | US20020086854 Methods and compositions using norastemizole in combination with leukotriene inhibitors |
| 07/04/2002 | US20020086833 Cocoa procyanidin oligomer/polymer, a polyphenol-type compound; anticancer agent; antioxidant; DNA topoisomerase II enzyme inhibitors, cyclooxygenase, NO (Nitric Oxide) or NO-synthase modulators, nonsteroidal antiinflammatory agent |
| 07/04/2002 | US20020086832 Immunosuppressing a human after allogenic cell, tissue or organ transplantation by administering a caspase-8 inhibitor |
| 07/04/2002 | US20020086830 (HARC), and polynucleotides which encode it; agonists, antibodies, or antagonists specifically binding HARC, and their use in treating diseases associated with expression of HARC |
| 07/04/2002 | US20020086818 Combination therapy including 9-nitro-20(S)-camptothecin and 5-fluorouracil |
| 07/04/2002 | US20020086408 Ubiquitin-like conjugating protein |
| 07/04/2002 | US20020086401 Nucleotide sequences coding transport protein; for use generating antiproliferative agents |
| 07/04/2002 | US20020086385 Nucleotide sequences coding enzyymatic polypeptide for use in prevention of bacterial infection; bactericides |
| 07/04/2002 | US20020086381 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 07/04/2002 | US20020086360 Polypeptide for use in treatment of congestive heart failure, ischaemic heart defects, arrhytmias, cardioiomyopathy and stroke |
| 07/04/2002 | US20020086342 Detection of enzyme inhibitors; obtain sample, incubate with modulator, monitor sample for dephosphorylation, compare to control |
| 07/04/2002 | US20020086316 Reagents and methods useful for detecting diseases of the prostate |
| 07/04/2002 | US20020086308 Ribosome crystaline structure; for use in killing or prevention of propagation of target organism |
| 07/04/2002 | US20020086295 Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen |
| 07/04/2002 | US20020086284 Determining sensitivity of a cell to reovirus infection; obtain cells, monitor ras protein signaling, consistent signaling indicates sensitivity to reovirus infection |
| 07/04/2002 | US20020086282 Methods and compositions for detecting compounds that modulate inflammatory responses |
| 07/04/2002 | US20020086067 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses |
| 07/04/2002 | US20020086065 Methods and compositions for the benefit of those suffering from polycystic ovary syndrome with chromium complexes |
| 07/04/2002 | US20020086057 For therapy of urinary incontinence |
| 07/04/2002 | US20020086029 For use in inhibiting gastric acid secretion; therapy of gastric acid related diseases |
| 07/04/2002 | US20020086025 Antibodies that bind to alpha2-antiplasmin crosslinked to fibrin which do not inhibit plasma alpha2-antiplasmin |
| 07/04/2002 | US20020086020 Method for improving the half-life of soluble viral receptors on mucosal membranes |
| 07/04/2002 | US20020086018 Methods and compositions of matter concerning APRIL/G70, BCMA, BLYS/AGP-3, and TACI |
| 07/04/2002 | US20020086015 Compositions and methods for promoting nerve regeneration |